Monitoring HIV testing in diverse healthcare settings: results from a sentinel surveillance pilot study

Emily Tweed1, Antony Hale, Martin Hurrelle

  • 1Immunisation, Hepatitis and Blood Safety Department, Health Protection Agency, Centre for Infections, London, UK. emilytweed43@gmail.com

Insights

Sentinel laboratory surveillance effectively tracks HIV testing patterns. Most tests occur in genitourinary medicine and antenatal clinics, with 60% of positive cases being newly diagnosed.

Area of Science:

  • Infectious Disease Epidemiology
  • Public Health Surveillance
  • Clinical Laboratory Science

Background:

  • Understanding human immunodeficiency virus (HIV) testing trends is crucial for public health interventions.
  • Sentinel laboratory surveillance offers a potential method for monitoring HIV testing across diverse healthcare settings.
  • Current HIV testing is concentrated in specific clinical areas, necessitating broader surveillance strategies.

Purpose of the Study:

  • To evaluate the feasibility and utility of sentinel laboratory surveillance for monitoring HIV testing.
  • To analyze patterns and trends in HIV testing across various healthcare services.
  • To assess the proportion of newly diagnosed HIV cases identified through this surveillance method.

Main Methods:

  • Collected and analyzed data on all anti-HIV antibody tests conducted by Leeds Teaching Hospital Trust laboratory over 12 months.
  • Demographic information and the location of HIV testing were recorded.
  • Positive HIV tests were matched with the national HIV diagnosis database to identify newly diagnosed individuals.

Main Results:

  • Over 41,000 individuals were tested for HIV; 0.8% tested positive.
  • The majority of tests (77%) were performed in genitourinary medicine (GUM) clinics or antenatal care settings.
  • Of those who tested positive, 60% were newly diagnosed with HIV.

Conclusions:

  • Sentinel laboratory surveillance provides valuable demographic data and identifies trends in HIV testing.
  • Current HIV testing is limited outside of GUM and antenatal services.
  • Integrating HIV testing surveillance into existing hepatitis surveillance systems could enable rapid expansion with minimal resources.
Abstract